This study is looking into whether a treatment called AdiaVita, which uses umbilical cord blood-derived stem cells and exosomes, combined with glutathione, can help adults with chronic kidney disease (CKD). CKD means your kidneys are gradually losing their ability to filter blood. You might be able to join if you are 18-80 years old and have a confirmed CKD diagnosis (eGFR 15-89 mL/min/1.73 m²). The researchers want to see if AdiaVita plus glutathione improves kidney function better than other treatments, using blood tests like eGFR (estimated glomerular filtration rate) and creatinine levels. They also want to check if the treatment is safe and what side effects it might have. The study is currently recruiting about 100 participants.

Study design

This is a randomized, single-blind, controlled study with three groups of participants. About 100 adults will be enrolled.

What's involved

You would have monthly intravenous infusions for three months and use a topical spray twice daily. You would also need to attend all scheduled visits, get required bloodwork, and pay a $15,000 study fee.

Compensation

Not stated in the trial record.

Follow-up

Your kidney function will be measured at baseline and again at 6 months after starting the study. The total study duration per participant is 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.